Marinomed Biotech AG (VIE:MARI)
Austria · Delayed Price · Currency is EUR 5.30
+0.38 (7.72%)
Jul 21, 2026, 2:19 PM CET
Marinomed Biotech AG Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.95 | 1.71 | 2.56 | 8.18 | 5.8 |
Cash & Short-Term Investments | 0.95 | 1.71 | 2.56 | 8.18 | 5.8 |
Cash Growth | -44.22% | -33.45% | -68.64% | 40.90% | -36.98% |
Accounts Receivable | 0.18 | 0.42 | 1.78 | 4.53 | 6.05 |
Other Receivables | 0.15 | 0.49 | 0.98 | - | - |
Total Trade Receivables | 0.33 | 0.91 | 2.76 | 4.53 | 6.05 |
Inventory | 0 | 0.54 | 0.89 | 1.56 | 1.03 |
Other Current Assets | - | - | - | 0 | - |
Total Current Assets | 1.29 | 3.15 | 6.22 | 14.27 | 12.88 |
Net Property, Plant & Equipment | 4.51 | 4.79 | 5.81 | 6.2 | 6.43 |
Other Intangible Assets | 0.01 | 0.09 | 0.13 | 1.8 | 2.01 |
Long-Term Investments | 0 | 0.02 | 0.04 | - | - |
Other Long-Term Assets | 0.14 | 0.14 | 0.17 | 0.01 | 0.02 |
Total Assets | 5.95 | 8.18 | 12.36 | 22.29 | 21.34 |
Accounts Payable | - | - | 1.53 | 1.15 | 1.99 |
Accrued Expenses | 0.63 | 0.87 | 0.82 | - | - |
Current Portion of Long-Term Debt | 5.34 | 28.23 | 7.58 | 2.45 | 0.75 |
Unearned Revenue | 0 | 0.47 | 0.08 | - | - |
Other Current Liabilities | 0.58 | 2.84 | 0.77 | 2.36 | 3.26 |
Total Current Liabilities | 6.55 | 32.41 | 10.79 | 5.96 | 6.01 |
Long-Term Debt | 6.07 | 0 | 12.81 | 20.18 | 15.04 |
Other Long-Term Liabilities | - | - | 1.1 | 0.3 | 0.09 |
Total Long-Term Liabilities | 6.07 | 0 | 13.91 | 20.49 | 15.13 |
Total Liabilities | 12.14 | 33.23 | 23.87 | 26.44 | 21.15 |
Common Stock | 1.84 | 1.78 | 1.52 | 1.51 | 1.48 |
Additional Paid-in Capital | 43.38 | 42.34 | 41.39 | 44.09 | 42.07 |
Accumulated Other Comprehensive Income | 0.66 | 0.66 | 0 | - | - |
Retained Earnings | -52.92 | -70.93 | -55.52 | -49.76 | -43.36 |
Total Common Shareholders' Equity | -7.05 | -26.16 | -12.6 | -4.16 | 0.19 |
Minority Interest | 0.86 | 1.11 | 1.09 | - | - |
Shareholders' Equity | -6.19 | -25.05 | -11.51 | -4.16 | 0.19 |
Total Liabilities & Equity | 5.95 | 8.18 | 12.36 | 22.29 | 21.34 |
Total Debt | 11.4 | 28.23 | 20.39 | 22.63 | 15.8 |
Net Cash (Debt) | -10.45 | -26.52 | -17.83 | -14.45 | -10 |
Net Cash Per Share | -5.68 | -14.91 | -11.74 | -9.64 | -6.77 |
Book Value | -7.05 | -26.16 | -12.6 | -4.16 | 0.19 |
Book Value Per Share | -3.83 | -14.71 | -8.30 | -2.77 | 0.13 |
Tangible Book Value | -7.06 | -26.25 | -12.73 | -5.96 | -1.82 |
Tangible Book Value Per Share | -3.84 | -14.76 | -8.39 | -3.98 | -1.23 |